Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Befimmo SA | BEFB | Apr 29, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 29, 2024 | 3 886.76 | +0.31 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 29, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 29, 2024 | 1.19 | 0.00 |
Belysse Group N.V. | BELYS | Apr 29, 2024 | 0.82 | -2.94 |
Biocartis Group NV | BCART | Apr 29, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 29, 2024 | 0.02 | 0.00 |
Biotalys | BTLS | Apr 29, 2024 | 3.04 | +1.33 |
Boeing | BOEI | Apr 29, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 29, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 29, 2024 | 3.76 | +0.94 |
Brederode S.A. | BREB | Apr 29, 2024 | 113.20 | +0.89 |
Campine nv | CAMB | Apr 29, 2024 | 75.00 | 0.00 |
Candela Invest | CAND | Apr 29, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 29, 2024 | 13.42 | +1.51 |
Celyad Oncology SA | CYAD | Apr 29, 2024 | 0.33 | -1.49 |
Cenergy Holdings | CENER | Apr 29, 2024 | 7.84 | +4.26 |
Chevron | CHTEX | Apr 29, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 29, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 29, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 29, 2024 | 63.30 | +2.10 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 29, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 29, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 29, 2024 | 43.68 | +0.69 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 29, 2024 | 259.00 | +1.17 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 29, 2024 | 7.61 | -0.78 |
Connect Group | CONN | Apr 29, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Apr 29, 2024 | 0.01 | 0.00 |
Cumulex NV | CLEX | Apr 29, 2024 | 1.15 | 0.00 |
CURETIS | CURE | Apr 29, 2024 | 0.29 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.